Letrozole bulk supplier for pharma manufacturers

Letrozole 2.5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2.5 mg

Reference Brands: Femara® (US & EU)

Letrozole (brand name Femara®) is an oral aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women. Approved in the US and EU, it comes in a 2.5 mg tablet. Widely available through B2B pharma channels, Letrozole is GMP-compliant and reliably supplied to hospitals and oncology centers at competitive prices

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Letrozole, sold under the brand name Femara®, is a highly effective aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Approved in both the US and EU, Letrozole is available in 2.5 mg oral tablets and is widely prescribed for early and advanced-stage breast cancer. As a key hormonal therapy, Letrozole is sourced globally by B2B pharmaceutical wholesalers, hospitals, and oncology clinics. With GMP-compliant manufacturing and reliable supply chains, Letrozole offers consistent quality and competitive pricing in the European and American markets, supporting cancer care with trusted pharmaceutical standards.

Letrozole — third party manufacturing & bulk supply

Letrozole 2.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Letrozole is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Letrozole listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Letrozole →

Back to Listing

Frequently Asked Questions

Letrozole is listed as Tablets in 2.5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Letrozole is referenced against Femara® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.